Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500102118Phase 4Recruiting
Phase 4 trial of propofol and oliceridine (2 arms), sponsored by The Affiliated Shunde Hospital of Jinan University. Primary endpoints: Body movement, Frown and 1 more. Started May 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500102118.